With healthcare systems buckling under workforce shortages, R&D costs spiraling into the billions, and aging populations demanding more than promises—the world’s most powerful health innovation leaders descended on Paris with a singular, urgent mission: kill the pilot programs that go nowhere and build the evidence engines that scale everywhere.